Pacer Advisors
ANAB icon

Pacer Advisors’s AnaptysBio ANAB Stock Holding History

Pacer Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-283
Closed -$7.09K – 2566
2024
Q2 		$7.09K Sell
283
-139
-33% -$3.24K ﹤0.01% 3601
2024
Q1 		$9.5K Buy
+422
New +$9.99K ﹤0.01% 3541
2021
Q2 		– Sell
-2,122
Closed -$46K – 1413
2021
Q1 		$46K Buy
2,122
+510
+32% +$12.9K ﹤0.01% 1445
2020
Q4 		$35K Sell
1,612
-250
-13% -$6.07K ﹤0.01% 1446
2020
Q3 		$27K Buy
+1,862
New +$33.6K ﹤0.01% 1343
2018
Q4 		– Sell
-3,699
Closed -$369K – 556
2018
Q3 		$369K Buy
+3,699
New +$307K 0.01% 915

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors's ANAB Position: Q3 2024 in Review

Pacer Advisors sold out of AnaptysBio (ANAB) in Q3 2024, closing a stake of 283 shares — an estimated $7.09K sold.

Pacer Advisors first reported a position in ANAB in Q3 2018 and held it in 6 quarters. The position peaked at $369K in Q3 2018. 160 funds tracked by Wall St. Rank hold ANAB as of Q3 2024.

  • Pacer Advisors reported no remaining AnaptysBio position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 283 AnaptysBio shares in Q3 2024, an estimated $7.09K.
  • Pacer Advisors first reported a position in AnaptysBio in Q3 2018 and held it in 6 quarters.
  • Pacer Advisors's AnaptysBio position peaked at $369K in Q3 2018.
  • 160 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.